The Obama administration has nominated Robert Califf, a researcher who conducted large clinical trials, as the next person to head the country’s drug approval agency.
The agency is soliciting opinions on a new technology that has the potential to circumvent mitochondrial diseases by producing embryos using DNA from three people.
Italian lawmakers have demanded formal approval for a controversial stem-cell therapy, but allowed some patients to continue treatment under stricter rules.